Cris Roxas

943 total citations
38 papers, 650 citations indexed

About

Cris Roxas is a scholar working on Physiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cris Roxas has authored 38 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 13 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cris Roxas's work include Asthma and respiratory diseases (32 papers), Eosinophilic Esophagitis (13 papers) and Respiratory and Cough-Related Research (6 papers). Cris Roxas is often cited by papers focused on Asthma and respiratory diseases (32 papers), Eosinophilic Esophagitis (13 papers) and Respiratory and Cough-Related Research (6 papers). Cris Roxas collaborates with scholars based in United Kingdom, Ireland and Canada. Cris Roxas's co-authors include G d’Ancona, Linda K. Green, David J. Jackson, Louise Thomson, Jaideep Dhariwal, Brian D. Kent, Mariana Fernandes, Joanne Kavanagh, Alexandra M. Nanzer and A Hearn and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Allergy.

In The Last Decade

Cris Roxas

36 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cris Roxas United Kingdom 12 576 483 156 137 124 38 650
Jean‐Pierre Llanos United States 14 476 0.8× 336 0.7× 152 1.0× 98 0.7× 114 0.9× 41 565
Mary Buatti Small United States 6 495 0.9× 396 0.8× 70 0.4× 115 0.8× 78 0.6× 7 546
K.M. Beeh Germany 4 847 1.5× 665 1.4× 427 2.7× 67 0.5× 98 0.8× 13 898
Luigi Zucchi Italy 11 283 0.5× 234 0.5× 90 0.6× 59 0.4× 73 0.6× 27 374
Sarah Diver United Kingdom 9 437 0.8× 322 0.7× 111 0.7× 57 0.4× 138 1.1× 26 587
Guy Peachey United Kingdom 12 707 1.2× 610 1.3× 303 1.9× 42 0.3× 58 0.5× 26 755
K. Surrey United Kingdom 4 1.1k 1.9× 816 1.7× 646 4.1× 76 0.6× 127 1.0× 9 1.2k
A B Löfroos Sweden 10 599 1.0× 565 1.2× 41 0.3× 39 0.3× 24 0.2× 10 660
Tracy Bridges United States 3 259 0.4× 252 0.5× 107 0.7× 22 0.2× 26 0.2× 3 332
Eva Martínez-Moragón Spain 11 192 0.3× 415 0.9× 51 0.3× 82 0.6× 20 0.2× 17 521

Countries citing papers authored by Cris Roxas

Since Specialization
Citations

This map shows the geographic impact of Cris Roxas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cris Roxas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cris Roxas more than expected).

Fields of papers citing papers by Cris Roxas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cris Roxas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cris Roxas. The network helps show where Cris Roxas may publish in the future.

Co-authorship network of co-authors of Cris Roxas

This figure shows the co-authorship network connecting the top 25 collaborators of Cris Roxas. A scholar is included among the top collaborators of Cris Roxas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cris Roxas. Cris Roxas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Green, Linda K., Mariana Fernandes, Louise Thomson, et al.. (2025). Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma. Allergy. 80(6). 1669–1676. 9 indexed citations
2.
d’Ancona, G, Linda K. Green, Mariana Fernandes, et al.. (2025). Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Tezepelumab Therapy for Severe Asthma. The Journal of Allergy and Clinical Immunology In Practice. 14(3). 637–643.e2.
3.
Nanzer, Alexandra M., Linda K. Green, Louise Thomson, et al.. (2024). Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis. The Journal of Allergy and Clinical Immunology In Practice. 12(3). 724–732. 13 indexed citations
4.
Hearn, A, Mariana Fernandes, Linda K. Green, et al.. (2024). Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology In Practice. 12(7). 1794–1800. 18 indexed citations
5.
d’Ancona, G, Joanne Kavanagh, Jaideep Dhariwal, et al.. (2021). Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma. Allergy. 76(7). 2238–2241. 18 indexed citations
6.
Hearn, A, Joanne Kavanagh, G d’Ancona, et al.. (2021). Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy. European Respiratory Journal. 57(6). 2100166–2100166. 3 indexed citations
7.
Dhariwal, Jaideep, A Hearn, Joanne Kavanagh, et al.. (2021). Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization. The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2315–2320.e1. 30 indexed citations
8.
9.
Nanzer, Alexandra M., Jaideep Dhariwal, Joanne Kavanagh, et al.. (2020). Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 6(4). 451–2020. 31 indexed citations
10.
d’Ancona, G, Joanne Kavanagh, Cris Roxas, et al.. (2020). Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma. European Respiratory Journal. 55(5). 1902259–1902259. 57 indexed citations
11.
Nanzer, Alexandra M., Cris Roxas, Mariana Fernandes, et al.. (2020). Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapy. European Respiratory Journal. 56(1). 1902273–1902273. 12 indexed citations
12.
Kent, Brian D., G d’Ancona, Mariana Fernandes, et al.. (2020). Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis. ERJ Open Research. 6(1). 311–2019. 26 indexed citations
13.
Kavanagh, Joanne, A Hearn, G d’Ancona, et al.. (2020). Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma. Allergy. 76(6). 1890–1893. 35 indexed citations
14.
Kavanagh, Joanne, A Hearn, Jaideep Dhariwal, et al.. (2020). Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma. CHEST Journal. 159(2). 496–506. 187 indexed citations
15.
Kavanagh, Joanne, G d’Ancona, Maria Elstad, et al.. (2020). Real-World Effectiveness and the Characteristics of a “Super-Responder” to Mepolizumab in Severe Eosinophilic Asthma. CHEST Journal. 158(2). 491–500. 126 indexed citations
16.
Hearn, A, G d’Ancona, Cris Roxas, et al.. (2020). The Response to Benralizumab at 1 Year After A Sub-Optimal Response to Mepolizumab in Severe Eosinophilic Asthma. A4265–A4265. 1 indexed citations
17.
18.
Roxas, Cris, et al.. (2019). P89 Real-world 1 year effectiveness of benralizumab in severe eosinophilic asthma. A138.1–A138. 2 indexed citations
19.
Jackson, David J., Cris Roxas, Mariana Fernandes, et al.. (2019). Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma. PA2527–PA2527. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Pierre Llanos Breakdown of academic impact, for papers by Mary Buatti Small Breakdown of academic impact, for papers by K.M. Beeh Breakdown of academic impact, for papers by Luigi Zucchi Breakdown of academic impact, for papers by Sarah Diver Breakdown of academic impact, for papers by Guy Peachey Breakdown of academic impact, for papers by K. Surrey Breakdown of academic impact, for papers by A B Löfroos Breakdown of academic impact, for papers by Tracy Bridges Breakdown of academic impact, for papers by Eva Martínez-Moragón
Rankless by CCL
2026